Risk of febrile seizures after first dose of measles–mumps–rubella–varicella vaccine: a population-b...
Risk of febrile seizures after first dose of measles–mumps–rubella–varicella vaccine: a population-based cohort study
About this item
Full title
Author / Creator
Publisher
Canada: Joule Inc
Journal title
Language
English
Formats
Publication information
Publisher
Canada: Joule Inc
Subjects
More information
Scope and Contents
Contents
AbstractBackgroundThe combination measles–mumps–rubella–varicella (MMRV) vaccine currently used in Canada (Priorix-Tetra) may increase the risk of febrile seizures relative to the separate vaccines (MMR and varicella) previously administered. We determined the risk of febrile seizure after the first dose of MMRV, as well as any additional risk for...
Alternative Titles
Full title
Risk of febrile seizures after first dose of measles–mumps–rubella–varicella vaccine: a population-based cohort study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4119141
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4119141
Other Identifiers
ISSN
0820-3946
E-ISSN
1488-2329
DOI
10.1503/cmaj.140078
